Literature DB >> 24761279

Caffeine Use Disorder: A Comprehensive Review and Research Agenda.

Steven E Meredith1, Laura M Juliano2, John R Hughes3, Roland R Griffiths4.   

Abstract

Caffeine is the most commonly used drug in the world. Although consumption of low to moderate doses of caffeine is generally safe, an increasing number of clinical studies are showing that some caffeine users become dependent on the drug and are unable to reduce consumption despite knowledge of recurrent health problems associated with continued use. Thus, the World Health Organization and some health care professionals recognize caffeine dependence as a clinical disorder. In this comprehensive literature review, we summarize published research on the biological evidence for caffeine dependence; we provide a systematic review of the prevalence of caffeine dependence and rates of endorsement of clinically meaningful indicators of distress and functional impairment among habitual caffeine users; we discuss the diagnostic criteria for Caffeine Use Disorder-a condition for further study included in the Diagnostic and Statistical Manual of Mental Disorders (5th ed.); and we outline a research agenda to help guide future clinical, epidemiological, and genetic investigations of caffeine dependence. Numerous controlled laboratory investigations reviewed in this article show that caffeine produces behavioral and physiological effects similar to other drugs of dependence. Moreover, several recent clinical studies indicate that caffeine dependence is a clinically meaningful disorder that affects a nontrivial proportion of caffeine users. Nevertheless, more research is needed to determine the reliability, validity, and prevalence of this clinically important health problem.

Entities:  

Year:  2013        PMID: 24761279      PMCID: PMC3777290          DOI: 10.1089/jcr.2013.0016

Source DB:  PubMed          Journal:  J Caffeine Res        ISSN: 2156-5368


  103 in total

1.  Differential glutamate-dependent and glutamate-independent adenosine A1 receptor-mediated modulation of dopamine release in different striatal compartments.

Authors:  Janusz Borycz; M Fátima Pereira; Alessia Melani; Ricardo J Rodrigues; Attila Köfalvi; Leigh Panlilio; Felicita Pedata; Steven R Goldberg; Rodrigo A Cunha; Sergi Ferré
Journal:  J Neurochem       Date:  2007-01-24       Impact factor: 5.372

2.  The course of a seasonal bipolar disorder influenced by caffeine.

Authors:  L Tondo; N Rudas
Journal:  J Affect Disord       Date:  1991-08       Impact factor: 4.839

3.  Physical dependence increases the relative reinforcing effects of caffeine versus placebo.

Authors:  B E Garrett; R R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  1998-10       Impact factor: 4.530

Review 4.  Coffee and health: a review of recent human research.

Authors:  Jane V Higdon; Balz Frei
Journal:  Crit Rev Food Sci Nutr       Date:  2006       Impact factor: 11.176

5.  Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption.

Authors:  Patrick Sulem; Daniel F Gudbjartsson; Frank Geller; Inga Prokopenko; Bjarke Feenstra; Katja K H Aben; Barbara Franke; Martin den Heijer; Peter Kovacs; Michael Stumvoll; Reedik Mägi; Lisa R Yanek; Lewis C Becker; Heather A Boyd; Simon N Stacey; G Bragi Walters; Adalbjorg Jonasdottir; Gudmar Thorleifsson; Hilma Holm; Sigurjon A Gudjonsson; Thorunn Rafnar; Gyda Björnsdottir; Diane M Becker; Mads Melbye; Augustine Kong; Anke Tönjes; Thorgeir Thorgeirsson; Unnur Thorsteinsdottir; Lambertus A Kiemeney; Kari Stefansson
Journal:  Hum Mol Genet       Date:  2011-02-28       Impact factor: 6.150

6.  Caffeine use as a model of acute and chronic insomnia.

Authors:  M H Bonnet; D L Arand
Journal:  Sleep       Date:  1992-12       Impact factor: 5.849

7.  Anxiety and depression associated with caffeinism among psychiatric inpatients.

Authors:  J F Greden; P Fontaine; M Lubetsky; K Chamberlin
Journal:  Am J Psychiatry       Date:  1978-08       Impact factor: 18.112

8.  Conditioned flavour preference negatively reinforced by caffeine in human volunteers.

Authors:  M R Yeomans; H Spetch; P J Rogers
Journal:  Psychopharmacology (Berl)       Date:  1998-06       Impact factor: 4.530

9.  Behavioral treatment of caffeinism: reducing excessive coffee drinking.

Authors:  R M Foxx; A Rubinoff
Journal:  J Appl Behav Anal       Date:  1979

10.  Associations between polymorphisms in the AHR and CYP1A1-CYP1A2 gene regions and habitual caffeine consumption.

Authors:  Andrea R Josse; Laura A Da Costa; Hannia Campos; Ahmed El-Sohemy
Journal:  Am J Clin Nutr       Date:  2012-08-01       Impact factor: 7.045

View more
  27 in total

Review 1.  Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity.

Authors:  Kay D Beharry; Gloria B Valencia; Douglas R Lazzaro; Jacob V Aranda
Journal:  Semin Perinatol       Date:  2016-01-29       Impact factor: 3.300

2.  Effects of chronic caffeine exposure during adolescence and subsequent acute caffeine challenge during adulthood on rat brain serotonergic systems.

Authors:  M R Arnold; P H Williams; J A McArthur; A R Archuleta; C E O'Neill; J E Hassell; D G Smith; R K Bachtell; C A Lowry
Journal:  Neuropharmacology       Date:  2018-12-20       Impact factor: 5.250

3.  Effects of caffeine and its metabolite paraxanthine on intracranial self-stimulation in male rats.

Authors:  Matthew F Lazenka; F Gerard Moeller; S Stevens Negus
Journal:  Exp Clin Psychopharmacol       Date:  2015-04       Impact factor: 3.157

4.  Pulse waveform analysis on temporal changes in ocular blood flow due to caffeine intake: a comparative study between habitual and non-habitual groups.

Authors:  Aishah Ismail; Mehwish S Bhatti; Ibrahima Faye; Cheng Kai Lu; Augustinus Laude; Tong Boon Tang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-06       Impact factor: 3.117

5.  Potentially addictive properties of sugar-sweetened beverages among adolescents.

Authors:  Jennifer Falbe; Hannah R Thompson; Anisha Patel; Kristine A Madsen
Journal:  Appetite       Date:  2018-10-29       Impact factor: 3.868

6.  Concurrent Validity of Caffeine Problems and Diagnostic Criteria for Substance Use Disorders.

Authors:  Elizabeth Harstad; Georgios Sideridis; Lon Sherritt; Lydia A Shrier; Rosemary Ziemnik; Sharon Levy
Journal:  J Caffeine Res       Date:  2016-12-01

7.  Cannabinoid Hyperemesis Syndrome: A Case Report and Discussion Regarding Patients with Concurrent Disorders.

Authors:  Stephen Lee-Cheong; Amrita Grewal; Lukas Hestvik; Reza Rafizadeh; Christian Schütz
Journal:  Can J Hosp Pharm       Date:  2020-10-01

8.  Chronic voluntary caffeine intake in male Wistar rats reveals individual differences in addiction-like behavior.

Authors:  Christine H Lee; Olivier George; Adam Kimbrough
Journal:  Pharmacol Biochem Behav       Date:  2020-02-24       Impact factor: 3.533

Review 9.  Evaluating the Validity of Caffeine Use Disorder.

Authors:  Alan J Budney; Dustin C Lee; Laura M Juliano
Journal:  Curr Psychiatry Rep       Date:  2015-09       Impact factor: 5.285

10.  Caffeine Use Disorder: A Review of the Evidence and Future Implications.

Authors:  Merideth A Addicott
Journal:  Curr Addict Rep       Date:  2014-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.